English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sir, Lichen planus ulcerosus, a rare variant in the clinical spectrum of lichen planus, leads to limited mobility, pain and disability. The  rst description of ulcerative lichen planus was written by Friedman (1), who already mentioned the combination with secondary anonychia (1, cf. 2). Since then, several case reports and small series have been published (2–8). The association of ulcerative plantar lichen planus with onychoatrophy and a variety of other autoimmune features has been classi ed as an autoimmune syndrome (7, 8). We describe here a female patient with a combination of ulcerative and hypertrophic lichen planus of the skin, oral lichen planus and secondary anonychia treated with systemic mycophenolate mofetil and UVA1. The plantar ulcers, however, were recalcitrant. Ulcer healing was induced by topical treatment with recombinant platelet-derived growth factor (PDGF)-BB.

Ulcerative Lichen Planus: A Case Responding to Recombinant Platelet-derived Growth Factor BB and Immunosuppression